全文获取类型
收费全文 | 1629篇 |
免费 | 210篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 33篇 |
妇产科学 | 22篇 |
基础医学 | 203篇 |
口腔科学 | 15篇 |
临床医学 | 210篇 |
内科学 | 560篇 |
皮肤病学 | 46篇 |
神经病学 | 69篇 |
特种医学 | 69篇 |
外科学 | 336篇 |
综合类 | 27篇 |
一般理论 | 1篇 |
预防医学 | 106篇 |
眼科学 | 15篇 |
药学 | 66篇 |
中国医学 | 1篇 |
肿瘤学 | 65篇 |
出版年
2021年 | 25篇 |
2019年 | 18篇 |
2018年 | 19篇 |
2017年 | 20篇 |
2016年 | 20篇 |
2015年 | 23篇 |
2014年 | 27篇 |
2013年 | 58篇 |
2012年 | 80篇 |
2011年 | 71篇 |
2010年 | 48篇 |
2009年 | 54篇 |
2008年 | 81篇 |
2007年 | 84篇 |
2006年 | 120篇 |
2005年 | 101篇 |
2004年 | 91篇 |
2003年 | 95篇 |
2002年 | 92篇 |
2001年 | 25篇 |
2000年 | 31篇 |
1999年 | 26篇 |
1998年 | 23篇 |
1997年 | 22篇 |
1996年 | 28篇 |
1995年 | 20篇 |
1994年 | 14篇 |
1993年 | 21篇 |
1992年 | 19篇 |
1991年 | 12篇 |
1990年 | 12篇 |
1989年 | 16篇 |
1986年 | 11篇 |
1985年 | 15篇 |
1984年 | 18篇 |
1983年 | 13篇 |
1982年 | 13篇 |
1981年 | 16篇 |
1980年 | 21篇 |
1979年 | 16篇 |
1978年 | 23篇 |
1977年 | 17篇 |
1976年 | 18篇 |
1975年 | 25篇 |
1974年 | 15篇 |
1973年 | 20篇 |
1972年 | 15篇 |
1966年 | 13篇 |
1964年 | 18篇 |
1962年 | 13篇 |
排序方式: 共有1855条查询结果,搜索用时 15 毫秒
1.
2.
3.
Adipsin gene expression is severely diminished in certain forms of genetic and acquired rodent obesity. Common to many of these models of obesity is decreased sympathetic nervous system (SNS) activity. In addition, treatment of MSG obese mice with the sympathomimetic drug mixture ephedrine and caffeine restores adipsin deficiency to normal, while reversing obesity. Based on these observations, we hypothesized that adipsin gene expression might be regulated through changes in SNS activity with deficient adipsin gene expression in obesity being the result of impaired SNS activity. In the present study we used three models to assess the role of the SNS in regulating adipsin gene expression. First we exposed mice to the cold (4 degrees C), a potent activator of SNS activity. Second, we chemically sympathectomized mice with 60H-dopamine. Third, we treated mice with BRL 26830A, an atypical beta adrenoreceptor agonist. In contrast to our initial hypothesis, these studies demonstrate that alterations of SNS activity do not affect adipsin gene expression in normal mice. Neither increased SNS activity secondary to cold exposure nor decreased SNS activity resulting from sympathectomy alter serum adipsin concentration or adipsin mRNA levels in white (WAT) and brown adipose tissue (BAT). Surprisingly, treatment of lean mice with BRL 26830A decreases both adipsin serum concentrations and adipsin mRNA levels, suggesting a potential role for atypical beta adrenoreceptors in pathways that suppress adipsin expression in vivo. The significance of this observation with respect to adipocyte physiology is unclear at present. Future studies will be aimed at defining the molecular mechanisms by which BRL 26830A suppresses adipsin gene expression and the physiological significance of this effect. 相似文献
4.
Perfluorochemicals as US contrast agents for tumor imaging and hepatosplenography: preliminary clinical results 总被引:3,自引:0,他引:3
Mattrey RF; Strich G; Shelton RE; Gosink BB; Leopold GR; Lee T; Forsythe J 《Radiology》1987,163(2):339-343
In animals, perfluorochemicals (PFCs) are effective ultrasound (US) contrast agents that produce hepatic, splenic, and tumor enhancement. The use of Fluosol-DA 20%, an emulsion of perfluorodecalin and perfluorotripropylamine, was studied in nine non-critically ill patients with cancer who had liver lesions. US studies without Fluosol were compared with studies obtained 24, 48, and 72 hours after Fluosol infusion. Vital signs and extensive laboratory analyses are performed before and after Fluosol infusion. Liver metastases from colonic, pancreatic, and gastric carcinoma exhibited rim or diffuse enhancement after a Fluosol dose of 1.6 g/kg or greater. Fluosol produced echogenic enhancement of the liver and spleen relative to kidney at a dose of 2.4 g/kg, allowing the detection of nonenhancing lesions. In addition, Fluosol at a dose of 1.6 g/kg or greater allowed detection of lesions not seen before contrast medium was administered in three of the seven patients studied. There was a mild increase in the level of serum glutamic oxaloacetic transaminase in two patients, one given 2.4 and the other 3.2 g/kg of Fluosol. Mild and transient allergic reactions without change in vital signs were experienced by two patients. 相似文献
5.
Classical and anaplastic seminoma: difference in survival 总被引:1,自引:0,他引:1
Classical and anaplastic seminoma are traditionally treated with radiation therapy and are said to have the same prognosis. A retrospective study was undertaken of 90 seminoma patients treated with radiation therapy between 1961 and 1985. The classical group consisted of 71 patients of whom 50 had stage I and 21 had stage II disease. The anaplastic group consisted of 19 patients of whom ten had stage I and nine had stage II disease. The median follow-up time was 64 months for the entire group. The 10-year relapse-free survival rate for the classical group was 94% and for the anaplastic group was 70% (P less than .05). For patients with classical stage I disease, the relapse-free actuarial survival rate was 98%; for patients with anaplastic stage I disease, it was 64% (P less than .02). For the classical stage II disease group, the relapse-free actuarial survival rate was 84% and for the anaplastic stage II disease group, 75% (P less than .70). Four patients in the classical group (6%) had relapses; of these, one patient had local recurrence of tumor, and three had distant metastases. In the anaplastic group, four patients (21%) had relapses; two patients had local recurrence of tumor, and two had distant metastases. Therefore the data suggest a difference in survival and relapse rates between classical and anaplastic seminoma. 相似文献
6.
7.
8.
9.
10.
Saijo K Schmedt C Su IH Karasuyama H Lowell CA Reth M Adachi T Patke A Santana A Tarakhovsky A 《Nature immunology》2003,4(3):274-279
The nature of signals that govern the development of immunoglobulin heavy chain-dependent B cells is largely unknown. Using mice deficient for the B cell-expressed Src-family protein tyrosine kinases (SFKs) Blk, Fyn and Lyn, we show an essential role of these kinases in pre-B cell receptor (pre-BCR)- mediated NF-kappaB activation and B cell development. This signaling defect is SFK specific, as a deficiency in Syk, which controls pre-B cell development, does not affect NF-kappaB induction. Impaired NF-kappaB induction was overcome by the activation of protein kinase C (PKC)-lambda, thus suggesting the involvement of PKC-lambda in pre-BCR-mediated SFK-dependent activation of NF-kappaB. Our data show the existence of a functionally distinct SFK signaling module responsible for pre-BCR-mediated NF-kappaB activation and B cell development. 相似文献